PDL BioPharma Inc. Reports 83% Rise In Q4 Earnings

(RTTNews) - PDL BioPharma Inc. (PDLI) revealed earnings for its fourth quarter that rose compared to the same period last year.

The company said its bottom line totaled $100.57 million, or $0.61 per share. This was higher than $55.07 million, or $0.32 per share, in last year's fourth quarter.

Analysts had expected the company to earn $0.54 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 52.1% to $178.06 million. This was up from $117.08 million last year.

PDL BioPharma Inc. earnings at a glance:

-Earnings (Q4): $100.57 Mln. vs. $55.07 Mln. last year. -Earnings Growth (Y-o-Y): 82.6% -EPS (Q4): $0.61 vs. $0.32 last year. -EPS Growth (Y-o-Y): 90.6% -Analysts Estimate: $0.54 -Revenue (Q4): $178.06 Mln vs. $117.08 Mln last year. -Revenue Change (Y-o-Y): 52.1%